Lack Of Risk Information In Nephrx’ Calcitriol Ad Draws FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
A print ad and product website for the generic injectable vitamin D3 supplement also overstate effectiveness and make unsubstantiated superiority claims, FDA’s ad division says.